Oxycodone DETERx, an extended-release, abuse-deterrent formulation for management of patients with chronic pain and chronic pain with dysphagia

被引：2
|
作者：
Kopecky, E. [1 ]
Fleming, A. [1 ]
Findlen, K. [1 ]
Mayock, S. [1 ]
Varanasi, R. [1 ]
Saim, S. [1 ]
机构：
[1] Coll Pharmaceu Inc, Canton, MA USA
来源：
JOURNAL OF PAIN | 2014年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jpain.2014.01.370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
459
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [41] Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone
    Severtson, Stevan Geoffrey
    Ellis, Matthew S.
    Kurtz, Steven P.
    Rosenblum, Andrew
    Cicero, Theodore J.
    Parrino, Mark W.
    Gilbert, Michael K.
    Buttram, Mance E.
    Dasgupta, Nabarun
    BucherBartelson, Becki
    Green, Jody L.
    Dart, Richard C.
    DRUG AND ALCOHOL DEPENDENCE, 2016, 168 : 219 - 229
  • [42] Opioid abuse-deterrent strategies: role of clinicians in acute pain management
    Webster, Lynn R.
    Brennan, Michael J.
    Kwong, Louis M.
    Levandowski, Richard
    Gudin, Jeffrey A.
    POSTGRADUATE MEDICINE, 2016, 128 (01) : 76 - 84
  • [43] FDA Approval of Extended-Release Oxycodone for Children With Severe Pain
    Yang, Y. Tony
    Chen, Brian
    Bennett, Charles L.
    PEDIATRICS, 2016, 137 (05)
  • [44] Long-Term Safety of Remoxy® (Extended-Release Oxycodone) in Patients with Moderate to Severe Chronic Osteoarthritis or Low Back Pain
    Friedmann, Nadav
    Klutzaritz, Vicki
    Webster, Lynn
    PAIN MEDICINE, 2011, 12 (05) : 755 - 760
  • [45] Effectiveness of Extended-Release Bupropion and Duloxetine on Pelvic Pain and Sexual Function among Patients with Chronic Prostatitis/Chronic Pelvic Pain
    Jaafari, Shokufe
    Molaeinezhad, Mitra
    Tarrahi, Mohammad J.
    Moosaei, Mohsen R.
    Sahfiei, Katayoun
    Afshar, Hamid
    ADVANCED BIOMEDICAL RESEARCH, 2024, 13 (01):
  • [46] Human abuse potential studies of abuse-deterrent opioids: lessons from oral and intranasal studies with morphine abuse-deterrent, extended-release, injection-molded tablets
    Webster, Lynn R.
    Viscusi, Eugene R.
    Brown, Colville
    Dayno, Jeffrey M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 893 - 901
  • [47] A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
    Jewell, Jennifer
    Black, Joshua
    Ellis, Matthew
    Olsen, Heather
    Iwanicki, Janetta
    Dart, Richard
    CLINICAL DRUG INVESTIGATION, 2023, 43 (03) : 197 - 203
  • [48] Societal Economic Benefits Associated with an Extended-Release Opioid with Abuse-Deterrent Technology in the United States
    Kirson, Noam Y.
    Shei, Amie
    White, Alan G.
    Birnbaum, Howard G.
    Ben-Joseph, Rami
    Rossiter, Louis F.
    Michna, Edward
    PAIN MEDICINE, 2014, 15 (09) : 1450 - 1454
  • [49] A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
    Jennifer Jewell
    Joshua Black
    Matthew Ellis
    Heather Olsen
    Janetta Iwanicki
    Richard Dart
    Clinical Drug Investigation, 2023, 43 : 197 - 203
  • [50] Tapentadol Extended Release for Chronic Pain Patients
    Taylor, Robert
    Pergolizzi, Joseph V.
    Raffa, Robert B.
    ADVANCES IN THERAPY, 2013, 30 (01) : 14 - 27
12345